Iterum Therapeutics PLC (ITRM)
1.55
-0.03
(-1.90%)
USD |
NASDAQ |
May 03, 16:00
1.53
-0.02
(-1.29%)
After-Hours: 20:00
Iterum Therapeutics Research and Development Expense (Quarterly): 9.744M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 9.744M |
| September 30, 2023 | 14.85M |
| June 30, 2023 | 8.964M |
| March 31, 2023 | 6.432M |
| December 31, 2022 | 5.84M |
| September 30, 2022 | 4.353M |
| June 30, 2022 | 3.984M |
| March 31, 2022 | 3.44M |
| December 31, 2021 | 3.702M |
| September 30, 2021 | 1.845M |
| June 30, 2021 | 2.714M |
| March 31, 2021 | 2.451M |
| December 31, 2020 | 2.351M |
| September 30, 2020 | 3.937M |
| Date | Value |
|---|---|
| June 30, 2020 | 5.043M |
| March 31, 2020 | 9.743M |
| December 31, 2019 | 20.88M |
| September 30, 2019 | 28.07M |
| June 30, 2019 | 24.44M |
| March 31, 2019 | 17.39M |
| December 31, 2018 | 21.46M |
| September 30, 2018 | 22.58M |
| June 30, 2018 | 13.72M |
| March 31, 2018 | 10.88M |
| December 31, 2017 | 8.241M |
| September 30, 2017 | 7.434M |
| June 30, 2017 | 5.29M |
| March 31, 2017 | 4.534M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
1.845M
Minimum
Sep 2021
28.07M
Maximum
Sep 2019
8.568M
Average
5.043M
Median
Jun 2020
Research and Development Expense (Quarterly) Benchmarks
| Alkermes PLC | 67.61M |
| Endo International PLC | 28.14M |
| Jazz Pharmaceuticals PLC | 222.85M |
| Medtronic PLC | 695.00M |
| Perrigo Co PLC | 29.60M |